Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts

NCT05862441 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT05862441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05862441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts
Lead sponsor
Universiteit Antwerpen
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2018
Completion date
December 31, 2019
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous warts